Wei Yue

机构：University of California, Berkeley, Tsinghua University · ORCID：0000-0003-0236-0184

发表论文 29 篇 · 总被引 439 次 · h-index 12

代表论文

Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade (2023 · ACS Nano · 被引 58)
A neutrophil mimicking metal-porphyrin-based nanodevice loaded with porcine pancreatic elastase for cancer therapy (2023 · Nature Communications · 被引 56)
Lactate‐Responsive Gene Editing to Synergistically Enhance Macrophage‐Mediated Cancer Immunotherapy (2023 · Small · 被引 45)
NIR-II Light Leveraged Dual Drug Synthesis for Orthotopic Combination Therapy (2022 · ACS Nano · 被引 38)
MOFs Modulate Copper Trafficking in Tumor Cells for Bioorthogonal Therapy (2024 · Nano Letters · 被引 27)
An All-in-One Bioorthogonal System for Precise Cancer Therapy (2022 · Chemistry of Materials · 被引 23)